Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Document Type
Year range
1.
Acute medicine & surgery ; 9(1), 2022.
Article in English | EuropePMC | ID: covidwho-2047010

ABSTRACT

Background In patients with coronavirus disease (COVID‐19) due to severe acute respiratory syndrome coronavirus 2 infection, pneumomediastinum has been increasingly reported in cases of noninvasive oxygen therapy, including high‐flow nasal cannula, and invasive mechanical ventilation. However, its pathogenesis is still not understood. Case Presentation We report two cases of pneumomediastinum in acute respiratory distress syndrome (ARDS) caused by COVID‐19. In both cases, control of spontaneous breathing with neuromuscular blocking agents resulted in resolution of pneumoperitoneum. Conclusion The improvement of pneumomediastinum with control of spontaneous breathing suggested patient self‐inflicted lung injury as a possible mechanism in this case series. In ARDS cases with pneumomediastinum, in addition to controlling plateau pressure with conventional lung protective ventilation, spontaneous breathing should be controlled if the patient’s inspiratory effort is suspected to be strong. Time‐series of radiographic results of a 67‐year‐old man with acute respiratory distress syndrome caused by COVID‐19 with pneumomediastinum. (A) Chest X‐ray 2 days before admission to the ICU showing pneumomediastinum (denoted by white arrows). (C) CT on the day of ICU admission after intubation showing pneumomediastinum with air tracking along the sheath of pulmonary vasculature, indicating the Macklin effect (denoted by white arrow). (D) CT on ICU day 4 showing improvement in pneumomediastinum by controlling spontaneous breathing.

2.
Acute Med Surg ; 9(1): e796, 2022.
Article in English | MEDLINE | ID: covidwho-2047448

ABSTRACT

Background: In patients with coronavirus disease (COVID-19) due to severe acute respiratory syndrome coronavirus 2 infection, pneumomediastinum has been increasingly reported in cases of noninvasive oxygen therapy, including high-flow nasal cannula, and invasive mechanical ventilation. However, its pathogenesis is still not understood. Case Presentation: We report two cases of pneumomediastinum in acute respiratory distress syndrome (ARDS) caused by COVID-19. In both cases, control of spontaneous breathing with neuromuscular blocking agents resulted in resolution of pneumoperitoneum. Conclusion: The improvement of pneumomediastinum with control of spontaneous breathing suggested patient self-inflicted lung injury as a possible mechanism in this case series. In ARDS cases with pneumomediastinum, in addition to controlling plateau pressure with conventional lung protective ventilation, spontaneous breathing should be controlled if the patient's inspiratory effort is suspected to be strong.

3.
SELECTION OF CITATIONS
SEARCH DETAIL